Literature DB >> 8639072

Rippling muscles and myasthenia gravis with rippling muscles.

C F Ansevin1, D P Agamanolis.   

Abstract

OBJECTIVE: To describe a patient with rippling muscles and myasthenia gravis.
DESIGN: Clinical, laboratory, electrophysiologic, and muscle biopsy data are reported.
SETTING: Medical office and hospital. PATIENT: We describe a patient with rippling muscles (as seen in rippling muscle disease) and myasthenia gravis (MG) with thymoma. There was no family history of rippling muscle disease in our patient. Diplopia and other symptoms of MG were initially overshadowed by the striking rippling phenomenon. The rippling resolved when the MG became florrid.
INTERVENTIONS: The patient was treated with pyridostigmine, prednisone, and plasmaphereses before removal of a thymoma. MAIN OUTCOME AND
RESULTS: His MG improved with treatment and the rippling has not recurred 4 months after thymectomy.
CONCLUSIONS: Rippling muscle disease is rare and usually inherited. Our patient with rippling muscles (but no family history of rippling muscle disease) and MG suggests that rippling muscles may also be triggered by an autoimmune phenomenon.

Entities:  

Mesh:

Year:  1996        PMID: 8639072     DOI: 10.1001/archneur.1996.00550020113023

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

1.  Acquired rippling muscle disease associated with mild myasthenia gravis: a case report.

Authors:  Sander M van Schaik; V I H Kwa; A J van der Kooi
Journal:  J Neurol       Date:  2009-03-07       Impact factor: 4.849

Review 2.  Autoimmune and paraneoplastic channelopathies.

Authors:  Steven Vernino
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 3.  Neuromuscular issues in systemic disease.

Authors:  Wolfgang Grisold; Anna Grisold
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 6.030

4.  Rippling Muscle Disease with Irregular Toe Jerks and Anti-acetylcholine Receptor Antibodies: Remission after Extended Thymectomy.

Authors:  Nanaka Yamaguchi; Shunichi Matsuda; Jun Matsumoto; Yoshikazu Ugawa; Jun Shimizu; Tatsushi Toda; Masahiro Sonoo; Toshihiro Yoshizawa
Journal:  Intern Med       Date:  2021-10-19       Impact factor: 1.282

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.